Pharmacovigilance Information

A Drug Safety & Medicines Information Resource
PharmacovigilanceInfo provides information on pre- and post- marketing pharmacovigilance in the UK, Europe & the USA.
The Concept of Pharmacovigilance

Before a new drug is authorised for sale to members of the public, it undergoes years of testing in both animals (pre-clinical) and human beings (clinical trials). These tests are done in order to understand how the drug will potentially work in humans and what adverse effects are likely to occur...To learn more about pharmacovigilance and its applications, click here.     

Report a side effect of a medicine

       UK Yellow Card Scheme


MedWatch logo US FDA Adverse Event Reporting Program
Site News

Drug safety alerts and other relevant information can now be sent directly to your email inbox. To subscribe, please enter your email address in the subscription box on this page.
FDA Medwatch Updates

only search


FDA MedWatch Learn
Do you need to report problems to the FDA?
 If so, click here to
practise the completion of Forms FDA 3500 and 3500B

Medicines info resources are available here.
Imodium abuse has recently resulted in multiple fatalities. Thus, the FDA wants manufacturers to (a) produce packages with only enough medication for short-term use, and (b) adopt unit dose packaging such as blister packs. Do you think these deterrents are sufficient?
Useful links

Enter your email address in the box below to receive drug alerts & recalls: